Brief: Natco Pharma Approves Investment Up To 14 Billion Rupees In Wholly Owned Subsidiary In South Africa
08/07/2026 07:37
BRIEF-Natco Pharma Approves Investment Up To 14 Billion Rupees In Wholly Owned Subsidiary In South Africa July 8 (Reuters) - Natco Pharma Ltd NATP.NS:
NATCO PHARMA - APPROVES INVESTMENT UP TO 14 BILLION RUPEES IN WHOLLY OWNED SUBSIDIARY IN SOUTH AFRICA
NATCO PHARMA - BOARD APPROVES INCREASING STAKE IN ADCOCK INGRAM HOLDINGS TO 49%
Source text: ID:nBSE5hXgBn
Further company coverage: NATP.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Natco Pharma
See all newsBrief: Natco Pharma Launches Carboplatin Injection In Us With Teyro Labs
India's Natco Pharma jumps after launching ovarian cancer drug in US
Brief: Natco Pharma Announces Launch Of Carboplatin Injection In The U.S. Market
Brief: Natco Pharma To Increase Its Investment In Egenesis To $16.70 Million
Brief: Natco Pharma Approves Rights Issue Up To 12.79 Billion Rupees